XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning Balance (in shares) at Dec. 31, 2020     93.5          
Beginning Balance at Dec. 31, 2020 $ 1,126.2   $ 0.1 $ 1,849.7   $ 1.8 $ (725.4)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 74.4           74.4  
Unrealized loss on debt securities available-for-sale, net of tax (1.1)         (1.1)    
Stock-based compensation expense 61.5     61.5        
Issuances of common stock under stock plans (in shares)     1.1          
Issuances of common stock under stock plans 18.2     18.2        
Ending Balance (in shares) at Jun. 30, 2021     94.6          
Ending Balance at Jun. 30, 2021 1,279.2   $ 0.1 1,929.4   0.7 (651.0)  
Beginning Balance (in shares) at Mar. 31, 2021     94.5          
Beginning Balance at Mar. 31, 2021 1,205.6   $ 0.1 1,897.8   1.0 (693.3)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 42.3           42.3  
Unrealized loss on debt securities available-for-sale, net of tax (0.3)         (0.3)    
Stock-based compensation expense 28.6     28.6        
Issuances of common stock under stock plans (in shares)     0.1          
Issuances of common stock under stock plans 3.0     3.0        
Ending Balance (in shares) at Jun. 30, 2021     94.6          
Ending Balance at Jun. 30, 2021 1,279.2   $ 0.1 1,929.4   0.7 (651.0)  
Beginning Balance (in shares) at Dec. 31, 2021     94.9          
Beginning Balance at Dec. 31, 2021 1,374.0 $ (32.3) $ 0.1 2,011.4 $ (106.8) (1.7) (635.8) $ 74.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (3.0)           (3.0)  
Unrealized loss on debt securities available-for-sale, net of tax (10.5)         (10.5)    
Stock-based compensation expense 86.5     86.5        
Issuances of common stock under stock plans (in shares)     0.7          
Issuances of common stock under stock plans 8.7     8.7        
Ending Balance (in shares) at Jun. 30, 2022     95.6          
Ending Balance at Jun. 30, 2022 1,423.4   $ 0.1 1,999.8   (12.2) (564.3)  
Beginning Balance (in shares) at Mar. 31, 2022     95.5          
Beginning Balance at Mar. 31, 2022 1,391.1   $ 0.1 1,947.7   (9.3) (547.4)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (16.9)           (16.9)  
Unrealized loss on debt securities available-for-sale, net of tax (2.9)         (2.9)    
Stock-based compensation expense 49.5     49.5        
Issuances of common stock under stock plans (in shares)     0.1          
Issuances of common stock under stock plans 2.6     2.6        
Ending Balance (in shares) at Jun. 30, 2022     95.6          
Ending Balance at Jun. 30, 2022 $ 1,423.4   $ 0.1 $ 1,999.8   $ (12.2) $ (564.3)